Search

everythinglearnresearchcommunity

for

Search:↓

Baricitinib is effective and safe for severe alopecia areata, working similarly with or without an atopic background.

Experts agree on how to manage sugar levels and skin reactions in patients taking the cancer drug alpelisib.

Dupilumab is effective and safe for treating moderate-to-severe atopic dermatitis in adolescents.

Ritlecitinib may be more effective for severe alopecia areata than conventional treatments.

Baricitinib helps regrow hair in adults with severe alopecia better than a placebo and is approved for treatment, but long-term effects are still unknown.

Belimumab effectively controls SLE disease activity and reduces steroid use.

Ritlecitinib is effective and safe for treating alopecia areata, promoting significant hair regrowth.

JAK1 inhibitors can help reduce itchiness in atopic dermatitis.

Upadacitinib may help treat difficult cases of systemic lupus erythematosus.

Oral minoxidil can help regrow hair lost from antibody-drug conjugate treatment.

Baricitinib shows promise for severe alopecia areata but isn't a cure and has side effects.

Ritlecitinib significantly improves scalp hair regrowth in alopecia areata patients over time.

Scientists found a new protein, AMY117, common in Alzheimer's patients, which could be important for treatment and diagnosis.

Eclipta alba may improve memory and help treat Alzheimer's disease.

Using an anti-ICAM-1 antibody with rapamycin improves hair transplant survival in monkeys.

Apremilast did not work for treating severe alopecia areata.

A special membrane with cell particles helps heal diabetic wounds faster.

HPDAlR nanoparticles greatly improve skin wound healing without toxicity.

An emollient PLUS balm with ADE-G1 significantly improved skin dryness and quality of life in cancer patients with xerosis.

A patient with multiple sclerosis developed skin reactions after Daclizumab treatment, requiring more data on the drug's effects.

Ritlecitinib effectively reduces severe hair loss in alopecia areata over 24 months.

A woman with a rare autoimmune disorder had a blister on her eye and unique immune reaction, which was effectively treated with medication.

The choice between belimumab and anifrolumab for treating lupus depends on the patient's specific symptoms.

Patients with severe alopecia areata felt better and less anxious or depressed when treated with baricitinib compared to placebo.

Ethinylestradiol/chlormadinone acetate may be an effective and well-tolerated treatment for skin conditions caused by excess androgens.

Dupilumab can help regrow hair and improve skin conditions in patients with severe atopic dermatitis and alopecia areata.

Alopecia universalis from alemtuzumab in multiple sclerosis can be reversed with specific treatments.

Upadacitinib helps most people with alopecia regrow hair quickly and is generally safe.

Baricitinib improved hair loss and arthritis in a lupus patient.

Adding baricitinib will increase costs but offers more treatment options for alopecia areata.